201 related articles for article (PubMed ID: 33482324)
1. Transcriptome-wide differences between Saccharomyces cerevisiae and Saccharomyces cerevisiae var. boulardii: Clues on host survival and probiotic activity based on promoter sequence variability.
Pais P; Oliveira J; Almeida V; Yilmaz M; Monteiro PT; Teixeira MC
Genomics; 2021 Mar; 113(2):530-539. PubMed ID: 33482324
[TBL] [Abstract][Full Text] [Related]
2. New biomarkers underlying acetic acid tolerance in the probiotic yeast Saccharomyces cerevisiae var. boulardii.
Samakkarn W; Vandecruys P; Moreno MRF; Thevelein J; Ratanakhanokchai K; Soontorngun N
Appl Microbiol Biotechnol; 2024 Jan; 108(1):153. PubMed ID: 38240846
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
Datta S; Timson DJ; Annapure US
J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
[TBL] [Abstract][Full Text] [Related]
4. Novel insights in genetic transformation of the probiotic yeast Saccharomyces boulardii.
Douradinha B; Reis VC; Rogers MB; Torres FA; Evans JD; Marques ET
Bioengineered; 2014; 5(1):21-9. PubMed ID: 24013355
[TBL] [Abstract][Full Text] [Related]
5. Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast
Offei B; Vandecruys P; De Graeve S; Foulquié-Moreno MR; Thevelein JM
Genome Res; 2019 Sep; 29(9):1478-1494. PubMed ID: 31467028
[TBL] [Abstract][Full Text] [Related]
6. Effect of microencapsulation on
Ghorbani-Choboghlo H; Nikaein D; Khosravi AR; Rahmani R; Farahnejad Z
Iran J Microbiol; 2019 Apr; 11(2):160-165. PubMed ID: 31341571
[TBL] [Abstract][Full Text] [Related]
7. Fungemia following Saccharomyces cerevisiae var. boulardii probiotic treatment in an elderly patient.
Landaburu MF; López Daneri GA; Relloso S; Zarlenga LJ; Vinante MA; Mujica MT
Rev Argent Microbiol; 2020; 52(1):27-30. PubMed ID: 31262611
[TBL] [Abstract][Full Text] [Related]
8. Alcoholic and non-alcoholic rosé wines made with Saccharomyces cerevisiae var. boulardii probiotic yeast.
Mulero-Cerezo J; Tuñón-Molina A; Cano-Vicent A; Pérez-Colomer L; Martí M; Serrano-Aroca Á
Arch Microbiol; 2023 Apr; 205(5):201. PubMed ID: 37081186
[TBL] [Abstract][Full Text] [Related]
9. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.
Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G
Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314
[TBL] [Abstract][Full Text] [Related]
10. A Tunable and Expandable Transactivation System in Probiotic Yeast
Kwak S; Mahmud B; Dantas G
ACS Synth Biol; 2022 Jan; 11(1):508-514. PubMed ID: 34939781
[TBL] [Abstract][Full Text] [Related]
11. β-Galactomannan and Saccharomyces cerevisiae var. boulardii modulate the immune response against Salmonella enterica serovar Typhimurium in porcine intestinal epithelial and dendritic cells.
Badia R; Brufau MT; Guerrero-Zamora AM; Lizardo R; Dobrescu I; Martin-Venegas R; Ferrer R; Salmon H; Martínez P; Brufau J
Clin Vaccine Immunol; 2012 Mar; 19(3):368-76. PubMed ID: 22301691
[TBL] [Abstract][Full Text] [Related]
12. Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory.
Jin Y; Yu S; Liu JJ; Yun EJ; Lee JW; Jin YS; Kim KH
Microb Cell Fact; 2021 Aug; 20(1):160. PubMed ID: 34407819
[TBL] [Abstract][Full Text] [Related]
13. In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains.
van der Aa Kühle A; Skovgaard K; Jespersen L
Int J Food Microbiol; 2005 May; 101(1):29-39. PubMed ID: 15878404
[TBL] [Abstract][Full Text] [Related]
14. Health-promoting properties of
Ansari F; Alian Samakkhah S; Bahadori A; Jafari SM; Ziaee M; Khodayari MT; Pourjafar H
Crit Rev Food Sci Nutr; 2023; 63(4):457-485. PubMed ID: 34254862
[No Abstract] [Full Text] [Related]
15. Application of Saccharomyces cerevisiae var. boulardii in food processing: a review.
Lazo-Vélez MA; Serna-Saldívar SO; Rosales-Medina MF; Tinoco-Alvear M; Briones-García M
J Appl Microbiol; 2018 Oct; 125(4):943-951. PubMed ID: 29961970
[TBL] [Abstract][Full Text] [Related]
16. Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae.
Edwards-Ingram L; Gitsham P; Burton N; Warhurst G; Clarke I; Hoyle D; Oliver SG; Stateva L
Appl Environ Microbiol; 2007 Apr; 73(8):2458-67. PubMed ID: 17293506
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic.
Wombwell E; Bransteitter B; Gillen LR
Mycoses; 2021 Dec; 64(12):1521-1526. PubMed ID: 34585799
[TBL] [Abstract][Full Text] [Related]
18. A Mutation in
Liu JJ; Zhang GC; Kong II; Yun EJ; Zheng JQ; Kweon DH; Jin YS
Appl Environ Microbiol; 2018 May; 84(10):. PubMed ID: 29523547
[TBL] [Abstract][Full Text] [Related]
19. Use of Saccharomyces cerevisiae var. boulardii in co-fermentations with S. cerevisiae for the production of craft beers with potential healthy value-added.
Capece A; Romaniello R; Pietrafesa A; Siesto G; Pietrafesa R; Zambuto M; Romano P
Int J Food Microbiol; 2018 Nov; 284():22-30. PubMed ID: 29990636
[TBL] [Abstract][Full Text] [Related]
20. Modeling the Ethanol Tolerance of the Probiotic Yeast Saccharomyces cerevisiae var. boulardii CNCM I-745 for its Possible Use in a Functional Beer.
Ramírez-Cota GY; López-Villegas EO; Jiménez-Aparicio AR; Hernández-Sánchez H
Probiotics Antimicrob Proteins; 2021 Feb; 13(1):187-194. PubMed ID: 32613533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]